Abstract
Background
Morbid obesity is associated with gastroesophageal reflux disease (GERD), which, in most cases, completely resolves after Roux-en-Y gastric bypass (RYGB). Patients with persistent or recurrent symptoms have limited surgical options. This study sought to evaluate the application of the Stretta procedure for patients with refractory GERD.
Methods
The medical records of all patients who underwent Stretta for refractory GERD after RYGB were reviewed. Demographic, preoperative, and postoperative reflux data were collected. Data are presented as mean ± standard error of the mean. The t-test was used for comparison purposes.
Results
Of 369 patients, 7 received Stretta 27 ± 6 months after RYGB. All were women with a mean age of 49 ± 2 years. All the patients had experienced prebypass GERD symptoms for a duration of 45 ± 8 months. The mean prebypass body mass index was 45 ± 2 kg/m2, and this was reduced to 29 ± 2 kg/m2 after laparoscopic RYGB (p < 0.001). Before Stretta, all patients underwent a 48-h Bravo pH study, which demonstrated reflux with a mean fraction time of 7% ± 2% for pH lower than 4. After Stretta, five patients had complete resolution of their symptoms, with normalization of pH studies (mean fraction time of 3% ± 0% for pH < 4). The follow-up period after Stretta was 20 ± 2 months. One patient did not have adequate relief of symptoms after Stretta, and one patient was lost to follow-up evaluation.
Conclusion
Stretta is a valid option in the treatment of persistent GERD for patients who have undergone gastric bypass. Further study is required to evaluate the long-term efficacy of this procedure.
Similar content being viewed by others
References
Cipolleta L, Rotondano G, Dughera L, Repici A, Bianco MA, DeAngelis C, Vingiani AM, Battaglia E (2005) Delivery of radiofrequency energy to the gastroesophageal junction (Stretta procedure) for the treatment of gastroesophageal reflux disease. Surg Endosc 19: 849–853
DeMaria EJ, Sugerman HJ, Kellum JM, Meador JG, Wolfe LG (2002) Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg 235: 640–645
Frezza EE, Ikramuddin S, Gourash W, Rakitt T, Kingston A, Luketich J, Schauer PR (2002) Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 16: 1027–1031
Locke RG, Talley NJ, Fett SL, Zinsmeister AR, Melton J (1999) Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106: 642–649
Mason EE, Printon KJ, Blommers TJ, Scott DH (1978) Gastric bypass for obesity after ten years experience. Int J Obes 2: 197–206
Perez AR, Moncure AC, Rattner DW (2001) Obesity adversely affects the outcome of antireflux operations. Surg Endosc 15: 986–989
Perry Y, Courcoulas AP, Fernando HC, Buenaventura PO, McCaughan JS, Luketich JD (2004) Laparoscopic Roux-en-Y gastric bypass for recalcitrant gastroesophageal reflux disease in morbidly obese patients. J Laparoendosc Surg 8: 19–23
Pories WJ, Macdonald KG, Morgan EJ, Sinha MK, Dohn GL, Swanson MS, Barakat HA, Khazanie PG, Legget-Frazier N, Long SD, O’brien KF, Caro JF (1992) Surgical treatment of obesity and its effect on diabetes: 10-year follow-up. Am J Clin Nutr 55: 582S–585S
Portale G, Filipi CJ, Peters JH (2004) A current assessment of endoluminal approaches to the treatment of gastroesophageal reflux disease. Surg Innov 11: 225–234
Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J (2000) Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 232: 515–529
Schauer PR, Ikramuddin S, Hamad G, Eid GM, Mattar SG, Cottam D, Ramanathan R, Gourash W (2003) Laparoscopic gastric bypass surgery: current technique. J Laparoendosc Adv Surg Tech A 13: 229–239
Smith CD, McKluskey DA, Rajad MA, Lieberman AB, Hunter JG (2005) When fundoplications fail: redo? Ann Surg 241: 861–869
Torquati A, Houston HL, Kaiser J, Holzman MD, Richards WO (2004) Long-term follow-up study of the Stretta procedure for the treatment of gastroesophageal reflux disease. Surg Endosc 18: 1475–1479
Triadafilopoulos G (2003) Stretta: an effective minimally invasive treatment for gastroesophageal disease. Am J Med 18(Suppl 3A): 192S–200S
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mattar, S.G., Qureshi, F., Taylor, D. et al. Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass. Surg Endosc 20, 850–854 (2006). https://doi.org/10.1007/s00464-006-0513-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-006-0513-6